Le Lézard
Classified in: Health
Subjects: RCL, PSF

Advisory - Certain vials of fertility drug Cetrotide recalled because of potential contamination


OTTAWA, ON, July 4, 2020 /CNW/ -

Summary
Products: Cetrotide 0.25mg

Issue: One lot of Cetrotide 0.25mg is being recalled because some vials may have missing stoppers, which could make the product unsterile.

What to do: Check the lot number on your product or contact your pharmacist to determine whether your product is subject to this recall. If you have a recalled product, do not take the medication. Contact your healthcare provider as soon as possible to obtain a replacement and avoid any interruption to your treatment.

Issue
Health Canada is advising Canadians that EMD Serono, a Division of EMD Inc. Canada, is recalling one lot of Cetrotide 0.25mg because some vials may have missing stoppers, which could make the product unsterile.

Cetrotide is used in fertility treatment to help women get pregnant by stopping the body from releasing an egg from the ovary (ovulation) early so that it can be released at the best time for pregnancy to occur.

An unsterile product could introduce microorganisms when injected under the patient's skin. This may result in a local infection, such as an abscess, or an infection of the skin and deeper underlying tissues (cellulitis). Some infections can be serious if they spread to the blood, bones, heart or other areas of the body.

In addition, some of the contents of the vial may have spilled out because of the missing stopper, so the patient may not receive the proper dose and the drug would not be as effective.

Health Canada will monitor the company's recall and inform Canadians if new safety information becomes available.

Who is affected
Patients who are taking Cetrotide 0.25mg.

Affected product

Company

Product Name

DIN

Strength

Lot

Expiry

EMD Serono, a Division of EMD Inc. Canada

Cetrotide

02247766

0.25mg

8J025C

09/2020

What consumers should do

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 08:40
QT Imaging Holdings, Inc. a medical device company engaged in research, development, and commercialization of innovative body imaging systems is proud to announce positive data regarding the diagnostic performance of QTI's Breast Acoustic CTTM Scans...

at 08:40
Veracyte, Inc. , a leading cancer diagnostics company, today announced that nine abstracts focused on its Decipher Prostate and Decipher Bladder Genomic Classifiers will be presented at AUA 2024, the annual meeting of the American Urological...

at 08:39
Good Clean Love, the trailblazing brand of natural and organic sexual and vaginal health products, is thrilled to announce a transformative phase in its journey. Under new CEO Brenda Demers, a seasoned executive with 20 years of experience from...

at 08:38
Gone are the days of mundane wooden backyard playsets. Veteran-owned brand, SwingSesh, sets a new standard by offering an innovative blend of play and fitness equipment. And in this day and age of screen time distractions, we could all use some more...

at 08:38
Today Homethrive announced their partnership with Capstone Health Alliance, a leading regional group purchasing organization that collaborates with hospitals and healthcare providers nationwide. Adding Homethrive as a benefit will allow Capstone...

at 08:37
Core Solutions, Inc., (Core) is pleased to announce the launch of Core Clinician Assist: Symptom Tracking, the latest addition to Core's innovative behavioral health artificial intelligence (AI) solutions. The Symptom Tracking tool uses AI to assess...



News published on and distributed by: